Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder
This study has been completed.
Study NCT00240721   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: October 14, 2005   Last Updated: May 18, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bipolar Disorders
Affective Disorders, Psychotic
Mood Disorders
Additional conditions recognized in this trial
Bipolar Disorder
Psychotic Disorders
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
topiramate
More general drug interventions related to this trial
Anti-Obesity Agents
Anticonvulsants
Central Nervous System Agents
Neuroprotective Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services